Castle Biosciences' Inventory rose 3161.9% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 3161.9%. This contributed to the annual value of $8.1 million for FY2024, which is 243.01% up from last year.
Latest data reveals that Castle Biosciences reported Inventory of $8.6 million as of Q3 2025, which was up 3161.9% from $8.4 million recorded in Q2 2025.
In the past 5 years, Castle Biosciences' Inventory registered a high of $8.6 million during Q3 2025, and its lowest value of $2.0 million during Q4 2021.
For the 5-year period, Castle Biosciences' Inventory averaged around $5.3 million, with its median value being $5.8 million (2023).
As far as peak fluctuations go, Castle Biosciences' Inventory skyrocketed by 9954.77% in 2023, and later tumbled by 1041.2% in 2025.
Quarter analysis of 5 years shows Castle Biosciences' Inventory stood at $2.0 million in 2021, then soared by 96.93% to $4.0 million in 2022, then skyrocketed by 99.55% to $7.9 million in 2023, then grew by 2.43% to $8.1 million in 2024, then rose by 6.33% to $8.6 million in 2025.
Its Inventory stands at $8.6 million for Q3 2025, versus $8.4 million for Q2 2025 and $6.8 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value